Invesco Dynamic Biotech & Genome ETF (PBE): Price and Financial Metrics ETF


Invesco Dynamic Biotech & Genome ETF (PBE): $76.17

-1.53 (-1.97%)

POWR Rating

Component Grades

Trade

NA

Buy & Hold

NA

Peer

NA

PBE Stock Price Chart Interactive Chart >

Price chart for PBE

PBE Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market

Current price $76.17 52-week high $84.86
Prev. close $77.70 52-week low $54.41
Day low $75.58 Volume 5,310
Day high $77.04 Avg. volume 8,011
50-day MA $76.11 Dividend yield 0.00001%
200-day MA $74.71

Invesco Dynamic Biotech & Genome ETF (PBE) ETF Bio


The investment objective of the Invesco Dynamic Biotech & Genome ETF is based on the Dynamic Biotech & Genome Intellidex. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances in biotechnology and genetic engineering and research.

PBE ETF Info

Issuer Invesco
Expense Ratio 0.58%
Underlying Index Dynamic Biotechnology & Genome Intellidex Index
Asset Class Equity
Sector Health & Biotech ETFs
Assets Under Management (AUM) 303.85M
Net Asset Value (NAV) $77.71
Options? Yes
Total Holdings 32

PBE Top Holdings

Symbol Company % of Total
RGEN Repligen Corp 5.56%
CTLT Catalent Inc 5.48%
TECH BIOTECHNE CORP 5.39%
INCY INCYTE CORP 4.98%
GILD GILEAD SCI 4.95%
AMGN Amgen Inc 4.86%
ILMN ILLUMINA INC 4.7%
BIIB BIOGEN INC 4.3%
PRTA Prothena Corp PLC 3.2%
BPMC Blueprint Medicines Corp 2.97%

PBE Price Returns

1-mo 0.33%
3-mo -1.38%
6-mo 6.84%
1-year 32.48%
3-year 31.36%
5-year 77.67%
YTD 8.61%
2020 25.66%
2019 18.65%
2018 -0.19%
2017 22.28%
2016 -22.90%

PBE Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full PBE Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8648 seconds.